Pharmacogenomic samples, testing and data handling

Current version

PDF iconReflection paper

Reference numberEMEA/CHMP/PGxWP/201914/06
KeywordsPharmacogenomics (PG), pharmacogenomic evaluation
DescriptionThis document highlights some key principles to be considered by both the pharmaceutical industry and the assessors for pharmacogenomics sampling in clinical trials intended for regulatory submission.

Document history

First version

Current version

PDF iconReflection paper

PDF iconOverview of comments

Published: 15/11/2007

Published: 02/04/2007

Related content

How useful was this page?

Add your rating